Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux

Clinical trial NCT03881787 · COMPLETED

Trial details

NCT number: NCT03881787
Sponsor: Dragonboat Biopharmaceutical Company Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2017-04-19
Primary completion: 2019-08-19
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.